M
Some people are losing too much weight in Retatrutide trial.
Randomized trial results of the experimental GLP-1, GIP, and glucagon drug shows that it may be too effective, while causing a whopping 11% of participants at the highest dose to drop out because of the severity of the side effects. In Optimizer, Victoria Song covered TikTok influencers pushing grey market knockoffs of “Ratatouille” and attempted to find out what was actually in them. (Please don’t buy shady “Retatrutide” from the internet.)
Follow topics and authors from this story to see more like this in your personalized homepage feed and to receive email updates.
Loading comments
Getting the conversation ready...
Most Popular
Most Popular
- OpenAI pauses training of its ‘most capable models’
- Leaks reveal a new Apple HomePod mini, iPad mini, and Apple TV 4K
- Can Apple Home’s AI camera features outsmart Amazon’s and Google’s? I put them to the test
- Can ‘eSUV’ e-bikes really go from trail to town?
- Gemini 4 is almost ready, says new Google DeepMind chief











